Market Cap
A$143.77 Billion
AUD as of July 1, 2024
US$95.75 Billion
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
CSL Limited is a biotechnology company providing products to treat and prevent serious human medical conditions. CSL is involved in the research, development, manufacturing, and marketing of a wide range of products including blood plasma derivatives, vaccines, antivenom, and cell culture reagents for medical and genetic research and manufacturing applications.
Australia
languages
Healthcare
languages
Biotechnology
Australia Healthcare
Australia Biotechnology
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.